#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
medScope.pro

News

zdravotnipersonal

Romiplostim in Newly Diagnosed ITP Resistant to 1st Line Treatment –⁠ Case Study

2. 10. 2023 Source: Immune Thrombocytopenia

In patients with immune thrombocytopenia (ITP), effectively stopping and controlling bleeding can be complicated in some cases. This includes scenarios such as open wounds. One way to stabilize platelet count can be through administering a thrombopoietin receptor agonist (TPO-RA). The following case study presents a successful treatment of newly diagnosed ITP.

klinickadata

Romiplostim in ITP Treatment –⁠ Data from German Clinical Practice

Real-world clinical practice data from Germany confirm the beneficial effect and safety profile of romiplostim in patients with immune thrombocytopenia (ITP), both newly diagnosed, persistent, and…
2. 10. 2023 Source: Immune Thrombocytopenia
pneumokok dite s mamou

Invasive Pneumococcal Disease –⁠ Current Czech Data

The number of reported cases of invasive pneumococcal disease (IPD) returned to levels comparable to those before the COVID-19 pandemic in 2022. Regarding age-specific morbidity, the most at-risk…
2. 10. 2023 Source: Regular Vaccination
Tabelty diuretik

Do Gliflozins Affect the Need to Use Diuretics?

Sodium-glucose cotransporter 2 inhibitors (SGLT2i, i.e., gliflozins) have advanced from their initial role in reducing hyperglycemia in the treatment of type 2 diabetes mellitus (DM2) to…
1. 10. 2023 Source: Heart Failure
DISKUZE

INTERACTIVE CASE STUDY: Treatment of glaucoma medications without preservatives –⁠ current trend

The use of glaucoma medications without preservatives has been a trend in recent years. You can try their clinical application in the role of a prescribing doctor in an interactive case study.…
28. 9. 2023 Source: Treatment of Glaucoma
novinkyvnemocnici

Rapid Strengthening and Long-term Stabilization –⁠ New Strategy for Sequential Treatment of Severe Osteoporosis

Osteoanabolics have long been considered a treatment modality for osteoporosis that is only considered when antiresorptive medication lacks the desired efficacy. However, their role has been shifting…
27. 9. 2023 Source: Osteoporosis – Trends in Sequential Therapy
amgenosteoporoza

Inhibition of Sclerostin in Osteoporosis Therapy

Romosozumab, a subcutaneously administered antibody against sclerostin, is one of the most potent osteoanabolics and appears to be a highly effective modality in the treatment of postmenopausal…
27. 9. 2023 Source: Osteoporosis – Trends in Sequential Therapy
Gabrhelík

Doc. Tomáš Gabrhelík: Pain treatment should be seriously addressed by all fields, especially in seniors

Chronic pain is often underestimated, especially in older and polymorbid patients. On the other hand, during self-treatment, many patients use inappropriate medication for a long time. The treatment…
27. 9. 2023 Source: Analgesia
léčebné konopí extrakt

Three times on the topic of therapeutic cannabis usage possibilities –⁠ case studies from Czech practice

The following case studies from real Czech practice describe three cases of patients with various diagnoses, indicated for cannabis extract administration. In the first case, there was significant…
27. 9. 2023 Source: Medical Cannabis
roztroušená skleroza 22

Ocrelizumab in the treatment of multiple sclerosis in real-world practice –⁠ a systematic review of published studies

In controlled study programs, ocrelizumab has demonstrated beneficial effects on improving clinical parameters in patients with multiple sclerosis, such as the annual relapse rate or confirmed…
27. 9. 2023 Source: Neurology - Multiple Sclerosis
krytí Zetuvit Plus Silicone Border

Innovation in Wound Healing: Zetuvit Plus Silicone Border for Optimal Wound Exudate Management

Excessive wound exudate can lead to delayed healing, skin damage around the wound, or leakage under the chosen dressing. Zetuvit Plus Silicone Border dressing with high absorbent and retention…
26. 9. 2023 Source: Wound Healing
ulcerative colitis

Current Data of Tofacitinib in the Treatment of IBD: What Improvements in Endoscopic and Histologic Outcomes Can Be Achieved?

The oral Janus kinase inhibitor (JAKi) tofacitinib is currently approved for the treatment of moderately to severely active ulcerative colitis (UC). Its efficacy and safety in this indication have…
20. 9. 2023 Source: Intestinal Inflammations
congres

Current News from ECCO 2023: Tofacitinib in the Treatment of Ulcerative Colitis in Real-World Practice

At the 18th ECCO Congress, held in March 2023 in Copenhagen, results from a Spanish real-world study were presented. This study evaluated the efficacy and safety of tofacitinib in the treatment of…
20. 9. 2023 Source: Intestinal Inflammations
karcinom nosohltanu

Proton radiotherapy in patients with nasopharyngeal carcinoma increases chances of successful treatment

Nasopharyngeal carcinoma mainly affects younger people. It tends to be aggressive but responds very well to treatment –⁠ up to 85% of patients with this diagnosis can achieve long-term tumor…
20. 9. 2023 Source: Proton Radiotherapy
roztroušená skleróza

Early Implementation of Highly Effective Therapy for Multiple Sclerosis

The ongoing debate about changing the approach to treating relapsing-remitting multiple sclerosis (RRMS) from an escalation strategy to the early implementation of highly effective therapy (HET) is…
20. 9. 2023 Source: Neurology - Multiple Sclerosis
1 … 22 23 24 25 26 … 115
Filter by speciality
Remove filters
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#